STRYKER CORP
USUSDSTRYKER CORP (LSE:0R2S) — Medical/Dental Instruments. Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 2. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.
Par uzņēmumu
- Tīmekļvietne
- stryker.com
- Investoru attiecības
- stryker.com/ir/en/index.html
- Nozare
- Health Care · Medical/Dental Instruments
- Galvenā mītne
- Portage, United States
- Izpilddirektors
- Kevin A. Lobo
- Darbinieki
- 22 000
- Dibināts
- 1946
- Apgrozībā esošās akcijas
- 383.57 milj. uz 2026-06-30
- Brīvā apgrozība
- 348.14 milj.
- Tirgus kapitalizācija
- 105.6 mljrd. USD
- Iekšējās personas
- 5.36%
- Institucionālie investori
- 82.84%
- Nozare (SIC)
- Surgical & Medical Instruments & Apparatus
- ISIN
- US8636671013
- LEI
- 5493002F0SC4JTBU5137
- Izmaksas koeficients
- 35.3%
- FCF
- 4.70 mljrd. USD28%
- Parāds
- 14.9 mljrd. USD2.5 g. FCF
- Dividenžu stāžs
- 34 g.
- Peļņa, FCF un izmaksātās dividendes — par 12 mēnešiem līdz 30.06.2026 (uzņēmuma jaunākais ziņojums).
Apraksts
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Dividendes
STRYKER CORP (SYK) izmaksā dividendes reizi ceturksnī. Pēdējo 12 mēnešu laikā tika samaksāts 3.52 USD par akciju (maksājumi: 4). Tas ir aptuveni 1.28% no pašreizējās akciju cenas. Pamatojoties uz maksājumu vēsturi, nākamais ex-dividendes datums tiek gaidīts ap 30.12.2026. Nepārtrauktu dividenžu gadi: 34.
| Ex-datums | Izmaksa | Summa | % | Veids | Tikeris |
|---|---|---|---|---|---|
| 2026-09-30 | 2026-10-30 | 0.8800 USD | 0.3/1.3 % | ceturkšņa | US:SYK |
| 2026-06-30 | 2026-07-31 | 0.8800 USD | 0.3/1.3 % | ceturkšņa | US:SYK |
| 2026-03-31 | 2026-04-30 | 0.8800 USD | 0.3/≈1.3 % | ceturkšņa | US:SYK |
| 2025-12-31 | 2026-01-30 | 0.8800 USD | 0.3/≈1.3 % | ceturkšņa | US:SYK |
| 2025-09-30 | 2025-10-31 | 0.8400 USD | 0.3/≈1.2 % | ceturkšņa | US:SYK |
Ziņas šonedēļ
Preses relīzes no uzņēmuma investoru mājaslapas, kas tiek atjauninātas katru dienu. Saites ved uz uzņēmuma mājaslapu. Virsraksti ir oriģinālvalodā, kā uzņēmuma mājaslapā.
Lielākie akcionāri
| Turētājs | Daļa | Akcijas | Pārskata datums |
|---|---|---|---|
| Blackrock Inc. | 7.15% | 27.41 milj. | 2026-06-30 |
| Vanguard Capital Managem… | 5.88% | 22.54 milj. | 2026-06-30 |
| JPMORGAN CHASE & CO | 4.5% | 17.26 milj. | 2026-06-30 |
| State Street Corporation | 4.05% | 15.53 milj. | 2026-06-30 |
| Greenleaf Trust | 3.97% | 15.23 milj. | 2026-06-30 |
| Price (T.Rowe) Associate… | 3.11% | 11.92 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.86% | 10.95 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.33% | 8.94 milj. | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.13% | 8.17 milj. | 2026-06-30 |
| Wellington Management Gr… | 2.13% | 8.17 milj. | 2026-06-30 |
| Geode Capital Management… | 2.04% | 7.82 milj. | 2026-06-30 |
| Morgan Stanley | 1.55% | 5.96 milj. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.21% | 4.66 milj. | 2026-07-31 |
| Fidelity Concord Street… | 1.16% | 4.46 milj. | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.1% | 4.22 milj. | 2026-08-31 |
| SELECT SECTOR SPDR TRT-S… | 0.65% | 2.48 milj. | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.63% | 2.43 milj. | 2026-04-30 |
| VANGUARD INDEX FUNDS-Van… | 0.53% | 2.02 milj. | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 0.5% | 1.93 milj. | 2026-04-30 |
| VANGUARD WELLINGTON FUND | 0.5% | 1.92 milj. | 2026-05-31 |
| LOBO KEVIN A (Chief Exec… | ≈0.06% | 222 952 | 2026-03-20 |
| PIERCE JAMES ANDREW (Off… | ≈0.02% | 83 889 | 2026-03-20 |
| STILES SPENCER S (Presid… | ≈0.02% | 77 720 | 2026-06-01 |
| BECKER YIN C (Officer) | ≈0.01% | 36 052 | 2025-03-21 |
| SILVERNAIL ANDREW K. (Di… | ≈0% | 18 465 | 2026-05-06 |
| MENON VIJU S (Officer) | ≈0% | 17 580 | 2026-03-20 |
| GOLSTON ALLAN C (Directo… | ≈0% | 14 895 | 2025-02-18 |
| CROTTY DYLAN BRAM (Offic… | — | — | 2026-08-21 |
| FINK MARY KATHRYN (Offic… | — | — | 2026-05-11 |
| STRYKER RONDA E (Directo… | — | — | 2026-08-19 |
